Patents for A61P 3 - Drugs for disorders of the metabolism (129,789)
09/1997
09/09/1997US5665748 Antidiabetic, hypolipidemic agents
09/09/1997US5665716 24-homo vitamin D derivatives, process for their production and pharmaceutical preparations obtained therefrom
09/09/1997US5665705 Adjuncts to insulin therapy
09/09/1997US5665389 Insulin, vibrio cholera zonula occludens toxin
09/09/1997CA2136820C Thio-substituted nitrogen-containing heterocyclic phosphonate compounds for treating abnormal calcium and phosphate metabolism
09/09/1997CA1339452C Enantiomers of citalopram and derivatives thereof
09/04/1997WO1997032022A2 Canine ob protein compositions and methods
09/04/1997WO1997031943A1 Use of a pharmaceutical composition comprising an appetite-suppressing peptide
09/04/1997WO1997031907A1 Substituted 4-hydroxy-phenylalcanoic acid derivatives with agonist activity to ppar-gamma
09/04/1997WO1997031648A1 Use of il-7 for treating auto-immune diseases and insulin-dependent diabetes mellitus in particular
09/04/1997WO1997031640A1 Combination therapy for osteoporosis
09/04/1997WO1997031634A1 At1 receptor antagonist for the stimulation of apoptosis
09/04/1997WO1997031546A1 Composition and its use as a food supplement or for lowering lipids in serum
09/04/1997CA2247503A1 Canine ob protein compositions and methods
09/04/1997CA2247138A1 Composition and its use as a food supplement or for lowering lipids in serum
09/04/1997CA2198980A1 Ortho-substituted benzoylguanidines, process for their preparation, their use as a medicament or diagnostic, and medicament comprising them
09/03/1997EP0792643A1 Use of an aldose reductase inhibitor for reducing non-cardiac tissue damage
09/03/1997EP0792641A1 Use of estrogen antagonists and estrogen agonists in inhibiting pathological conditions
09/03/1997EP0792640A2 Use of (E)-1-(4'-(2-alkylaminoethioxy)-phenyl)-1-(3'-hydroxyphenyl)-2-phenylbut-1-enes for inhibiting pathological conditions
09/03/1997EP0792290A1 Acylated insulin
09/03/1997EP0792289A1 Low molecular weight peptidomimetic growth hormone secretagogues
09/03/1997EP0792268A1 Hypolipidemic benzothiazepines
09/03/1997EP0792264A1 Sulfur-substituted azetidinone compounds useful as hypocholesterolemic agents
09/03/1997EP0639178B1 Anti-atherosclerotic aryl compounds
09/03/1997CN1158613A Novel use and noveld erivatives of imidazole, method for preparing same, novel intermediates thus obtained, medicinal applications of same and pharmaceutical compositions containing same
09/03/1997CN1158254A Glossy privet leaf extract with regulating blood fat and lowering blood sugar function, its separating method and use
09/03/1997CN1035766C Process for preparing n-sulfonyl-tetrahydro-£1,3|-dioxepino£5,6-b|-azirines
09/02/1997US5663375 Cell proliferation
09/02/1997US5663334 Process for preparing pyrimidyl imidazoles
09/02/1997US5663322 Precipitation
09/02/1997US5663201 Complexes with iron or aluminum
09/02/1997US5663187 Treatment of atherosclerosis with angiotensin II receptor blocking imidazoles
09/02/1997US5663186 Treatment of atherosclerosis with angiotensin II receptor blocking imidazoles
09/02/1997US5663183 Cerebral disorders
09/02/1997US5663171 For use in humans or animals
09/02/1997US5663165 Hypolipidaemic benzothiazepine compounds
09/02/1997US5663157 For treating hyperproliferative diseases
09/02/1997US5663156 Mixture of higher primary aliphatic alcohols, its obtention from sugar cane wax and its pharmaceutical uses
09/02/1997US5663146 Administering a synergistic combination to animals, including humans
09/02/1997US5662934 Vitamins, gemfibrozil
09/02/1997US5662918 Bone disorders, storage stable
09/02/1997CA1339416C Insulin derivatives
08/1997
08/28/1997WO1997030985A1 Benzothiophenes, and formulations and methods, using same
08/28/1997WO1997030709A1 Benzothiophenes, formulations containing same, and methods
08/28/1997WO1997030677A2 Pentafluorobenzenesulfonamides and analogs
08/28/1997CA2247130A1 Benzothiophenes, and formulations and methods, using same
08/28/1997CA2246721A1 Benzothiophenes, formulations containing same, and methods
08/28/1997CA2198571A1 Use of (e)-1-¬4'-(2-alkylaminoethioxy)phenyl|-1-(3'-hydroxyphenyl)-2-phenylbut-1-enes in inhibiting pathological conditions
08/27/1997EP0791603A2 Pure somatostatin antagonist and methods of use thereof
08/27/1997EP0791601A2 An agent promoting bone formation and inhibiting bone resorption
08/27/1997EP0791592A2 Azetidines
08/27/1997EP0791591A1 Benzothiophenes, formulations containing same, and methods
08/27/1997EP0791590A1 Benzothiophenes, and formulations and methods using same
08/27/1997EP0791355A1 Method of reducing tissue damage associated with ischemia
08/27/1997EP0791298A1 Growth promotion in chickens
08/27/1997EP0791009A1 Modified neuropeptide y receptors
08/27/1997EP0790996A1 Pyridazinoquinoline compounds
08/27/1997EP0790826A1 Dihydropyrimidines and uses thereof
08/27/1997EP0790824A1 2,2-dichloroalkane carboxylic acids, process for preparing the same, medicament containing the same, and use thereof for treating insulin resistance
08/27/1997EP0592438B1 Indole derivatives
08/27/1997EP0520005B1 Nitroxides for weight reduction
08/27/1997CN1158123A Benzoxazoles and pyridine derivatives useful in the treatment of the type II diabetes
08/27/1997CN1157827A Novel, ATP-sensitive potassium-channel proteins and genes for the same
08/27/1997CN1157826A Novel, ubiquitous potassium-channel proteins and genes for the same
08/27/1997CN1157822A Pharmaceutical compounds
08/27/1997CN1157719A Percutaneous applied medicine contained gestodene
08/27/1997CA2197751A1 Growth promotion in chickens
08/26/1997US5661187 10-substituted 1,8-dihydroxy-9 (10H) anthracenone pharmaceuticals
08/26/1997US5661174 Guanidinealkyl-1,1-bisphosphonic acid derivatives, process for their preparation and their use
08/26/1997US5661173 Administering an enzyme inhibitor treating diabetes
08/26/1997US5661158 Hypotensive agents, anticholesterol agents
08/26/1997US5661145 Treating or preventing atherosclerosis or reducing plasma cholesterol levels
08/26/1997US5661140 Treating psoriasis
08/26/1997US5660824 Muscle trophic factor
08/26/1997CA1339365C Oligopeptides and intermediates and processes for their manufacture
08/21/1997WO1997030042A1 Polyester cyclic compounds, their complexes and bonded bodies
08/21/1997WO1997029746A1 Inhibition of protein glycation and prevention of vasculopathy
08/21/1997WO1997029745A1 Zwitterionic compositions and methods as biological response modifiers
08/21/1997WO1997023613A3 Cell activation process and reagents therefor
08/21/1997CA2230639A1 Zwitterionic compositions and methods as biological response modifiers
08/20/1997EP0789764A1 A novel family of protease inhibitors, and other biologic active substances
08/20/1997EP0789760A2 Enzymatic method for modification of recombinant polypeptides
08/20/1997EP0789713A1 Antibodies
08/20/1997EP0789570A1 Oral hypoglycemic agents
08/20/1997EP0662954B1 Novel vitamin d analogues
08/20/1997EP0586589B1 Amylin or amylin analogue composition optionally containing insulin for the treatment of anorexia and related states
08/20/1997EP0579833B1 Ethanolamine derivatives with anti-pollakiuria activity
08/20/1997CN1157621A Proinsulin peptide compound for detecting and treating type I diabetes
08/20/1997CN1157615A Heterocyclic tachykinin receptor antagonists
08/20/1997CN1157566A Phosphonates and parathyroid hormone for osteoporosis
08/20/1997CN1157565A Method for treatment of osteoporosis using bone active phosphonates and parathyroid hormone
08/20/1997CN1157290A Recombinant obese (ob) proteins
08/20/1997CN1157288A Benzimidazole derivatives, their preparation and their therapeutic use
08/20/1997CN1035670C Method for preparing benzoheterocyclic compounds or its salt
08/20/1997CA2197833A1 Pure somatostatin antagonist and methods of use thereof
08/19/1997US5659027 Boronated compounds
08/19/1997US5658949 Inhibition of tumor necrosis factor by retinoic acid
08/19/1997US5658944 Anticholesterol agents
08/19/1997US5658933 Enzyme inhibitors of proline and lysine hydroxylases necessary for the biosynthesis of collagen; antifibrotic agents; respiratory, liver and skin disorders; atherosclerosis; antiscarring agents
08/19/1997US5658776 Generation of high titers of recombinant AAV vectors